Purdue Pharma asks bankruptcy judge to accept new settlement plan

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company's alleged role in the opioid crisis, months after the Supreme Court blocked a prior deal.

The bankrupt company announced Tuesday it had filed a Chapter 11 Plan of Reorganization in the U.S. Bankruptcy Court for the Southern District of New York.

In June of last year, the Supreme Court blocked a settlement deal, finding that the Sackler family who previously controlled Purdue Pharma could not be released from liability under federal law, despite contributing $6 billion to the settlement.

“Following the 2024 Supreme Court ruling, we doubled down on our commitment to work with our creditors to design a new Plan that delivers unprecedented value to those affected by the opioid crisis. Today’s filing is a major milestone in that effort,” Purdue Board Chair Steve Miller said in a statement.

"We and our creditors have worked tirelessly in mediation to build consensus and negotiate a settlement that will increase the total value provided to victims and communities, put billions of dollars to work on day one, and serve the public good," Miller added. "I sincerely thank our stakeholders for their dedication and collaboration, and I look forward to having the plan confirmed and consummated as quickly as possible.”

In January, Purdue Pharma and the Sacklers agreed in principle to pay a $7.4 billion settlement to resolve the multitude of lawsuits, raising the settlement by an additional $1.4 billion. Tuesday's court filing expands on this plan.

Purdue Pharma argued this reorganization is likely to succeed, writing, "The Debtors’ reorganization is plainly in the public interest and favored by a balancing of the harms. The Debtors’ proposed plan will devote billions of dollars to public opioid abatement and creditor recoveries."

Topics

Purdue Pharma submits opioid lawsuit settlement plan, including up to $7 billion cash from Sacklers

Members of the Sackler family who own the OxyContin maker Purdue Pharma would hand over the company and up to $7 billion in cash in the latest plan to settle thousands of lawsuits over the toll of ...
ABC News - 21h
Potential $7.4B Purdue Pharma opioid settlement frustrates some victims

Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy bankruptcy case says.
CBS News - Mar. 9
Claimant: Opioid victims not getting justice in proposed Purdue settlement

Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.
CBS News - Mar. 9
Statement of Purdue Pharma to 60 Minutes

Purdue Pharma provided the following statement for 60 Minutes' report Sunday, "The Settlement."
CBS News - Mar. 9
3/9/2025: Firing the Watchdogs; The Settlement; A Method to this Madness

First, a report on the significance of President Trump firing independent government watchdogs. Then, a look inside the Purdue Pharma bankruptcy case. And, Dan Hurley: The 60 Minutes Interview.
CBS News - Mar. 10
Newsmax reveals it agreed to pay Smartmatic $40M in settlement with the voting machine company

Newsmax agreed to pay Smartmatic $40 million as part of a settlement last year following the voting technology company’s election defamation lawsuit against the right-wing news outlet, according to ...
NBC News - 5d
Mallinckrodt and Endo to combine after emerging from bankruptcy linked to opioid crisis

Groups have resolved billions of dollars in claims for selling highly addictive painkillers
Financial Times - 6d
Purdue star Trey Kaufman-Renn alleges racist comments made by Illinois fans toward 13-year-old brother

Purdue is reportedly planning to file a report to the Big Ten over the incident
CBS Sports - Mar. 8
Forever 21 Operator Files for Bankruptcy

The company, which helped popularize fast fashion in the United States, has struggled to compete with online retailers. It is the company’s second bankruptcy filing in six years.
The New York Times - 2d